1. Abstract 1.1. Background: Capecitabine is an oral prodrug used for the treatment of various cancer diseases. Capecitabine is activated to 5-FU. The most severe adverse effect is “hand-foot syndrome.
Incidence of Hand-Foot Syndrome in Patients with Breast Cancer on Capecitabine Treatment Read More »
1. Case Series A 36-year-old male with a past medical history of Acute Lymphoblastic Leukemia and type 2 diabetes was transferred to the Upstate Medical University Hospital for continuation of chemotherapy. The patient initially presented to a local hospital with epistaxis and was originally treated for immune thrombocytopenic purpura with intravenous immunoglobulins and steroids. DOI:https://doi.org/10.47829/ACMCR.2023.11404
Impact Factor 4.787*
Annals of Clinical and Medical Case Reports® is an esteemed and zealous in publishing various scientific and medical journals which acts as a shell that provides latest research information for all the researchers across the world.
Address: 500 N. Rainbow Blvd, Suite 300, Las Vegas, Nevada 89107 USA.
Email: submission@acmcasereport.us
Phone: +1 7755157689
You cannot copy content of this page